Charmaine O'Neill

Charmaine O'Neill has extensive experience in clinical operations and project management within the biopharmaceutical industry, currently serving as Vice President of Clinical Operations at Vantage Biosciences. Prior roles include Global Trials Director and Associate Director of Clinical Operations at Gyroscope Therapeutics, where O'Neill contributed to clinical trial development, as well as Senior Global Project Manager at Aimmune Therapeutics, focusing on desensitization treatments for food allergies. O'Neill's career also includes significant positions at hVIVO Ltd., Syneos Health, and Silveira Research, emphasizing programme management and strategic development in clinical research. Educational qualifications include a BSc (Hons) in Pharmacology from Liverpool University and a BSc (Hons) in Psychology from London Metropolitan University. Additionally, O'Neill holds a Diplome en la langue francaise from Universite de Reims, reflecting a strong foundation in both scientific and language skills.